Arkolith/Insider Trading/NBY/Form 4/A

Framework Ventures IV GP LLC

10% OwnerNovaBay Pharmaceuticals, Inc. (NBY) · full profile →Form 4/A · filed Oct 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 16, 2025Other(J)221K—$0221K
Oct 16, 2025Other(J)134K—$0134K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001829126-25-008355) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML